BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 30818928)

  • 1. [Differences of brain functional alterations between subtypes of Cushing's syndrome patients].
    Liu DD; Zhou W; Li PL; Zhang JL; Chen W; Gu WJ; Pei Y; Du J; Zang L; Ba JM; Lü ZH; Mu YM; Shan BC; Zhang YL; Ma L; Dou JT
    Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(8):593-598. PubMed ID: 30818928
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of chronic hypercortisolemia on affective processing.
    Langenecker SA; Weisenbach SL; Giordani B; Briceño EM; Guidotti Breting LM; Schallmo MP; Leon HM; Noll DC; Zubieta JK; Schteingart DE; Starkman MN
    Neuropharmacology; 2012 Jan; 62(1):217-25. PubMed ID: 21787793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Newell-Price J; Morris DG; Drake WM; Korbonits M; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1640-5. PubMed ID: 11932295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine carcinoma of the thyroid causing adrenocorticotrophic hormone-dependent Cushing's syndrome.
    Dutta D; Mukhopadhyay S; Maisnam I; Ghosh S; Mukhopadhyay P; Chowdhury S
    Thyroid; 2013 Jan; 23(1):120-3. PubMed ID: 23140512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas.
    Klose M; Jørgensen K; Kristensen LØ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):394-9. PubMed ID: 15355458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of adrenal iodomethylnorcholesterol uptake to indices of adrenal cortical function in Cushing's syndrome.
    Gross MD; Valk TW; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1062-6. PubMed ID: 6262361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH-independent Cushing's syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures.
    Wei J; Li S; Liu Q; Zhu Y; Wu N; Tang Y; Li Q; Ren K; Zhang Q; Yu Y; An Z; Chen J; Li J
    BMC Endocr Disord; 2018 Apr; 18(1):22. PubMed ID: 29685132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive Functioning in Temporal Lobe Epilepsy: A BOLD-fMRI Study.
    Guo L; Bai G; Zhang H; Lu D; Zheng J; Xu G
    Mol Neurobiol; 2017 Dec; 54(10):8361-8369. PubMed ID: 27924527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Etiology analysis of 522 hospitalized cases with Cushing syndrome].
    Li LL; Dou JT; Yang GQ; Gu WJ; Lü ZH; Mu YM
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(31):2454-7. PubMed ID: 27562041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cushing's syndrome: diagnostic exploration].
    Tabarin A; Roger P
    Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW; Kehoe ME; Shaker JL; Raff H
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of efficacy between the serum cortisol and 24 hour urine free cortisol in combined dexamethasone suppression test in the diagnosis of Cushing syndrome].
    Lu L; Chen JH; Zhu HJ; Song AL; Li M; Chen S; Pan H; Gong FY; Wang RZ; Xing B; Yao Y; Feng M; Lu ZL
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2150-4. PubMed ID: 27464539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease.
    Arvat E; Ramunni J; Giordano R; Maccagno B; Broglio F; Benso A; Deghenghi R; Ghigo E
    J Endocrinol Invest; 1999 Jan; 22(1):23-8. PubMed ID: 10090133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.